AT7519
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT7519, covering 2025-02-10 to 2025-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]